The Helsinki Stock Exchange opened its doors on Thursday and after a while of trading, the general index of the exchange was up 0.2 percent at 9808.57 points. Faron Pharmaceuticals was the most traded stock, whose share was down 2.8 percent at 1.64 euros. A drug development company, Faron, announced that it had completed a directed offering of 4.8 million euros to a limited group of institutional and other investors, and stated that it expects to need EUR 27 million more capital to implement phase 2 of the Bexmab study.
In March, the Helsinki stock exchange experienced significantly less trade than in the corresponding period last year, according to Nordnet trading statistics. The number of trades on the entire Helsinki Stock Exchange decreased by 34.9 percent in March from the previous March, with the exchange denominated in euros falling by 30.3 percent from a year ago. The stock exchange’s general index fell by approximately three percent during the first quarter.
Inderes raised Homecoming to an increase level of recommendation from the previous decrease level, with a repeated target price of EUR 28.00. OP raised Wärtsilä’s target price to 14
